CS
AGRX

Credit Suisse’s Agile Therapeutics AGRX Stock Holding History

Credit Suisse’s Portfolio AGRX Stock Details AGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-9
Closed -$23K – 4618
2021
Q2 		$23K Buy
+9
New +$29.7K ﹤0.01% 4420
2021
Q1 		– Sell
-11
Closed -$64K – 4661
2020
Q4 		$64K Buy
+11
New +$64.7K ﹤0.01% 4226
2020
Q2 		– Sell
-24
Closed -$90K – 4212
2020
Q1 		$90K Sell
24
-60
-71% -$344K ﹤0.01% 3847
2019
Q4 		$418K Buy
+84
New +$293K ﹤0.01% 3660
2017
Q3 		– Sell
-19
Closed -$142K – 4285
2017
Q2 		$142K Buy
+19
New +$132K ﹤0.01% 3683

Other funds holding AGRX

PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $528B AUM 27.57% 1-Year Est. Return
NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return